Regenerative Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4094974
- 143 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Regenerative market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Regenerative market segmented into
Dermatology
Tissue Engineering
Biomaterial
Others
Based on the end-use, the global Regenerative market classified into
Dermatology
Cardiovascular
CNS
Orthopedic
Others
Based on geography, the global Regenerative market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL REGENERATIVE INDUSTRY
2.1 Summary about Regenerative Industry
2.2 Regenerative Market Trends
2.2.1 Regenerative Production & Consumption Trends
2.2.2 Regenerative Demand Structure Trends
2.3 Regenerative Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Cell Therapy
4.2.2 Tissue Engineering
4.2.3 Biomaterial
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Dermatology
4.3.2 Cardiovascular
4.3.3 CNS
4.3.4 Orthopedic
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Cell Therapy
5.2.2 Tissue Engineering
5.2.3 Biomaterial
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Dermatology
5.3.2 Cardiovascular
5.3.3 CNS
5.3.4 Orthopedic
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Cell Therapy
6.2.2 Tissue Engineering
6.2.3 Biomaterial
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Dermatology
6.3.2 Cardiovascular
6.3.3 CNS
6.3.4 Orthopedic
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Cell Therapy
7.2.2 Tissue Engineering
7.2.3 Biomaterial
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Dermatology
7.3.2 Cardiovascular
7.3.3 CNS
7.3.4 Orthopedic
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Cell Therapy
8.2.2 Tissue Engineering
8.2.3 Biomaterial
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Dermatology
8.3.2 Cardiovascular
8.3.3 CNS
8.3.4 Orthopedic
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Cell Therapy
9.2.2 Tissue Engineering
9.2.3 Biomaterial
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Dermatology
9.3.2 Cardiovascular
9.3.3 CNS
9.3.4 Orthopedic
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 DePuy Synthes
10.1.2 Medtronic
10.1.3 ZimmerBiomet
10.1.4 Stryker
10.1.5 Acelity
10.1.6 MiMedx Group
10.1.7 Organogenesis
10.1.8 UniQure
10.1.9 Cellular Dynamics International
10.1.10 Osiris Therapeutics
10.1.11 Vcanbio
10.1.12 Gamida Cell
10.1.13 Golden Meditech
10.1.14 Cytori
10.1.15 Celgene
10.1.16 Vericel Corporation
10.1.17 Guanhao Biotech
10.1.18 Mesoblast
10.1.19 Stemcell Technologies
10.1.20 Bellicum Pharmaceuticals
10.2 Regenerative Sales Date of Major Players (2017-2020e)
10.2.1 DePuy Synthes
10.2.2 Medtronic
10.2.3 ZimmerBiomet
10.2.4 Stryker
10.2.5 Acelity
10.2.6 MiMedx Group
10.2.7 Organogenesis
10.2.8 UniQure
10.2.9 Cellular Dynamics International
10.2.10 Osiris Therapeutics
10.2.11 Vcanbio
10.2.12 Gamida Cell
10.2.13 Golden Meditech
10.2.14 Cytori
10.2.15 Celgene
10.2.16 Vericel Corporation
10.2.17 Guanhao Biotech
10.2.18 Mesoblast
10.2.19 Stemcell Technologies
10.2.20 Bellicum Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Regenerative Product Type Overview
2.Table Regenerative Product Type Market Share List
3.Table Regenerative Product Type of Major Players
4.Table Brief Introduction of DePuy Synthes
5.Table Brief Introduction of Medtronic
6.Table Brief Introduction of ZimmerBiomet
7.Table Brief Introduction of Stryker
8.Table Brief Introduction of Acelity
9.Table Brief Introduction of MiMedx Group
10.Table Brief Introduction of Organogenesis
11.Table Brief Introduction of UniQure
12.Table Brief Introduction of Cellular Dynamics International
13.Table Brief Introduction of Osiris Therapeutics
14.Table Brief Introduction of Vcanbio
15.Table Brief Introduction of Gamida Cell
16.Table Brief Introduction of Golden Meditech
17.Table Brief Introduction of Cytori
18.Table Brief Introduction of Celgene
19.Table Brief Introduction of Vericel Corporation
20.Table Brief Introduction of Guanhao Biotech
21.Table Brief Introduction of Mesoblast
22.Table Brief Introduction of Stemcell Technologies
23.Table Brief Introduction of Bellicum Pharmaceuticals
24.Table Products & Services of DePuy Synthes
25.Table Products & Services of Medtronic
26.Table Products & Services of ZimmerBiomet
27.Table Products & Services of Stryker
28.Table Products & Services of Acelity
29.Table Products & Services of MiMedx Group
30.Table Products & Services of Organogenesis
31.Table Products & Services of UniQure
32.Table Products & Services of Cellular Dynamics International
33.Table Products & Services of Osiris Therapeutics
34.Table Products & Services of Vcanbio
35.Table Products & Services of Gamida Cell
36.Table Products & Services of Golden Meditech
37.Table Products & Services of Cytori
38.Table Products & Services of Celgene
39.Table Products & Services of Vericel Corporation
40.Table Products & Services of Guanhao Biotech
41.Table Products & Services of Mesoblast
42.Table Products & Services of Stemcell Technologies
43.Table Products & Services of Bellicum Pharmaceuticals
44.Table Market Distribution of Major Players
45.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
46.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
47.Table Global Regenerative Market Forecast (Million USD) by Region 2021f-2026f
48.Table Global Regenerative Market Forecast (Million USD) Share by Region 2021f-2026f
49.Table Global Regenerative Market Forecast (Million USD) by Demand 2021f-2026f
50.Table Global Regenerative Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
